there are too may potential combinations, and pre-clinical algorithms for predicting the most effi cacious combination are yet in their infancy. These efforts have been, and will likely continue to be led astray if methods of target identifi cation and elucidation of signaling pathway connections rely too heavily on genomics, without necessary attention to the context of metabolic pathways, enzymes, and post-translational modifi cations, which can be defi ned by proteomics. Empiric combination therapies based on clinical observations of astute observers remains a welcome means of discovery of optimal combinations. In the present issue, the report of using gefi tinib and radiation for carcinomatous encephalitis is intriguing in this respect, and suggest a clinically utilizable general radiosensitizing effect of gefi tinib, if confi rmed in larger controlled studies.
The idea of combining multiple targeted therapeutics to treat disorders of complex pathophysiology is extended to asthma by the though provoking article by Popescu (2007) . Such therapeutics could promise the potential of a relatively long-term remission from asthma without even the need for rescue medications. The issues regarding systemic or local adverse reactions would be exponentially magnifi ed by multi-targeting. Insuffi cient knowledge of the effects of such interventions on cellular metabolic pathways could potentially result in combinations that are inherently antagonistic. We need not look far to fi nd examples where combining targeted biologicals has not improved effi cacy. There are no clear-cut explanations to the observations regarding the relative failure of targeted therapeutics, other than the obvious complexity of disease pathology, or inaccurate models of signaling that have poorly defi ned connections to metabolic pathways or cellular processes. In the face of these obstacles, it is reassuring that discovery of novel therapeutic combinations could result from ingenious cross-disciplinary collaborations that are subject of several articles in the current issue.
